References

Baylor College of Medicine website. https://www.bcm.edu/research/medical-genetics-labs/test_detail.cfm?testcode=32750&show=1. Accessed April 23, 2018.

Byers PH, Belmont J, Black J, et al. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017;175(1):40-47.

Christian Hendrickz. Rare Disease Impact Report: Insights from patients and the medical community. http://www.academia.edu/18842593/Rare_Disease_Impact_Report_Insights_from_patients_and_the_medical_community. Accessed January 5, 2018.

Chu LC, Johnson PT, Dietz HC, et al. Vascular complications of Ehlers-Danlos syndrome: CT findings. AJR Am J Roentgenol. 2012;198(2):482-487.

Data on File - Acer Therapeutics

Frank M, Albuisson J, Ranque B, et al. The types of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome. Eur J Hum Genet. 2015;23(12):1657-1664.

MedlinePlus. U.S. National Library of Medicine website https://medlineplus.gov/mplusdictionary.html. Updated April 18, 2012. Accessed January 5, 2018.

Nawarskas JJ, Cheng-Lai A, Frishman WH. Celiprolol – a unique selective adrenoceptor modulator. Cardiol Rev. 2017;25(5):247-253.

Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342(10):673-680.

Pepin MG, Schwarze U, Rice KM, Liu M, Leistritz D, Byers PH. Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV). Genet Med. 2014;16(12):881-888.

Pepin MG, Murray ML, Byers PH. Vascular Ehlers-Danlos Syndrome. GeneReviews^®. Seattle (WA): University of Washington, Seattle; September 1999, last updated November 2015.

Voermans NC, Knoop H, Bleijenberg G, van Engelen BG. Pain in Ehlers-Danlos Syndrome is common, severe, and associated with functional impairment. J Pain Symptom Manage. 2010;40(3):374.